These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 12570803)

  • 1. Heparin derivatives as angiogenesis inhibitors.
    Presta M; Leali D; Stabile H; Ronca R; Camozzi M; Coco L; Moroni E; Liekens S; Rusnati M
    Curr Pharm Des; 2003; 9(7):553-66. PubMed ID: 12570803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Undersulfated and glycol-split heparins endowed with antiangiogenic activity.
    Casu B; Guerrini M; Guglieri S; Naggi A; Perez M; Torri G; Cassinelli G; Ribatti D; Carminati P; Giannini G; Penco S; Pisano C; Belleri M; Rusnati M; Presta M
    J Med Chem; 2004 Feb; 47(4):838-48. PubMed ID: 14761186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
    Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.
    Chiodelli P; Bugatti A; Urbinati C; Rusnati M
    Molecules; 2015 Apr; 20(4):6342-88. PubMed ID: 25867824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization.
    Rusnati M; Presta M
    Int J Clin Lab Res; 1996; 26(1):15-23. PubMed ID: 8739851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Undersulfated, low-molecular-weight glycol-split heparin as an antiangiogenic VEGF antagonist.
    Pisano C; Aulicino C; Vesci L; Casu B; Naggi A; Torri G; Ribatti D; Belleri M; Rusnati M; Presta M
    Glycobiology; 2005 Feb; 15(2):1C-6C. PubMed ID: 15496501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis and angiogenesis inhibitors: a new potential anticancer therapeutic strategy.
    Ranieri G; Gasparini G
    Curr Drug Targets Immune Endocr Metabol Disord; 2001 Nov; 1(3):241-53. PubMed ID: 12477290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
    Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
    Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-FGF2 approaches as a strategy to compensate resistance to anti-VEGF therapy: long-pentraxin 3 as a novel antiangiogenic FGF2-antagonist.
    Alessi P; Leali D; Camozzi M; Cantelmo A; Albini A; Presta M
    Eur Cytokine Netw; 2009 Dec; 20(4):225-34. PubMed ID: 20167562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of angiogenesis: Biologic implications for antiangiogenic therapy.
    Ellis LM; Liu W; Ahmad SA; Fan F; Jung YD; Shaheen RM; Reinmuth N
    Semin Oncol; 2001 Oct; 28(5 Suppl 16):94-104. PubMed ID: 11706401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
    Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
    Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparins and angiogenesis.
    Norrby K
    APMIS; 2006 Feb; 114(2):79-102. PubMed ID: 16519745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of angiogenesis in tumor growth and metastasis.
    Folkman J
    Semin Oncol; 2002 Dec; 29(6 Suppl 16):15-8. PubMed ID: 12516034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyproline-type helical-structured low-molecular weight heparin (LMWH)-taurocholate conjugate as a new angiogenesis inhibitor.
    Lee E; Kim YS; Bae SM; Kim SK; Jin S; Chung SW; Lee M; Moon HT; Jeon OC; Park RW; Kim IS; Byun Y; Kim SY
    Int J Cancer; 2009 Jun; 124(12):2755-65. PubMed ID: 19243020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of sodium deoxycholate (DOC) conjugated heparin derivatives for inhibition of angiogenesis and cancer cell growth.
    Cho KJ; Moon HT; Park GE; Jeon OC; Byun Y; Lee YK
    Bioconjug Chem; 2008 Jul; 19(7):1346-51. PubMed ID: 18588324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Heparanase-Mediated Angiogenesis Using Microvascular Endothelial Cells: Identification of λ-Carrageenan Derivative as a Potent Anti Angiogenic Agent.
    Poupard N; Badarou P; Fasani F; Groult H; Bridiau N; Sannier F; Bordenave-Juchereau S; Kieda C; Piot JM; Grillon C; Fruitier-Arnaudin I; Maugard T
    Mar Drugs; 2017 May; 15(5):. PubMed ID: 28486399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis: basic and clinical aspects.
    Ribatti D; Vacca A; Nico B; Presta M; Roncali L
    Ital J Anat Embryol; 2003; 108(1):1-24. PubMed ID: 12737512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiangiogenic function of antithrombin is dependent on its conformational variation: implication for other serpins.
    Azhar A; Singh P; Rashid Q; Naseem A; Khan MS; Jairajpuri MA
    Protein Pept Lett; 2013 Apr; 20(4):403-11. PubMed ID: 23016581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.